Task: Answer the MCQ question.
Query: Which compound exhibits a -34.492% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a) N#CC(=C1CCCC1)c1nc(-c2cc3ccccc3oc2=O)cs1
b) CCOc1ccc(S(=O)(=O)Nc2cccc(C(=O)NCC(C)(C)N3CCOCC3)c2)cc1
Answer: b. CCOc1ccc(S(=O)(=O)Nc2cccc(C(=O)NCC(C)(C)N3CCOCC3)c2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOc1ccc(S(=O)(=O)Nc2cccc(C(=O)NCC(C)(C)N3CCOCC3)c2)cc1
CCOc1ccc(S(=O)(=O)Nc2cccc(C(=O)NCC(C)(C)N3CCOCC3)c2)cc1
3-[(4-ethoxyphenyl)sulfonylamino]-N-(2-methyl-2-morpholin-4-ylpropyl)benzamide